Inclisiran found Safe and Effective for Lowering LDL in Low-Risk Patients: Study Dr. Prem Aggarwal13 Jun 2025 9:00 AM ISTAccording to a new study inclisiran, given as a twice-yearly injection, significantly lowers LDL cholesterol in low-risk patients who are not on any...
PCSK9 Inhibitors May Reduce Risk of Vitiligo,Promising New Therapeutic Approach, reports study Dr Riya Dave24 Aug 2024 4:00 AM ISTResearchers have found that PCSK9 inhibitors, a class of lipid-lowering agents, may be associated with a sharply decreased incidence of developing...
No impact of PCSK9 inhibitors on glucose metabolism among patients of hypercholesterolemia with prediabetes Medha Baranwal12 Jan 2024 8:30 PM ISTSpain: A recent real-life study published in Cardiovascular Diabetology has shed light on the impact of PCSK9 inhibitors in glycaemic control and...
New PCSK9 inhibitor halves LDL with 3 monthly dosing: AHA 2023 dr. Abhimanyu Uppal16 Nov 2023 6:30 PM ISTThe results from the REMAIN-2 trial presented recently at AHA 2023 conference have shown that Recaticimab, a novel, long-acting PCSK9 inhibitor that...
Aggressive LDL Cholesterol Lowering Not Linked to Cognitive Impairment or Hemorrhagic Stroke Risk: AHA Medha Baranwal21 Sept 2023 11:45 AM ISTUSA: The American Heart Association (AHA) has released a new scientific statement reinforcing that treating patients to achieve very low levels of LDL...
Cholesterol lowering drugs for high heart risk patients must be added Dr. Nandita Mohan16 May 2022 11:00 AM ISTA panel of international experts and patients in The BMJ said that additional cholesterol- lowering drugs should be offered to patients with high...
Reduction of CV events by PCSK9 inhibitors and ezetimibe: Clinical practice guideline Dr. Kamal Kant Kohli13 May 2022 9:30 AM ISTAdditional cholesterol lowering drugs should be offered to patients with high levels of 'bad' (LDL) cholesterol (70 mg/dl or higher) who are also at...
PCSK9 inhibitors safer than statins in people with elevated risk of hemorrhagic stroke: Study Medha Baranwal26 Jun 2021 9:00 AM ISTUSA: A recent study comparing the lipid-lowering therapies statin and PCSK9 inhibitors found statin to be associated with an increased risk of...
Cholesterol drug combinations could cut complications risk in CV patients Hina Zahid29 Aug 2020 12:30 PM ISTNew findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk...
PCSK9 inhibitors may slow progression of aortic stenosis Dr. Kamal Kant Kohli1 May 2020 11:33 AM ISTEvolocumab (Repatha) decreases LDL cholesterol and has significant impact on Myocardial infarction type and size. Researchers in an additional...
PCSK9 Inhibitors also lower Venous Thromboembolism risk: Study Dr. Kamal Kant Kohli26 April 2020 6:00 PM ISTThe researchers have found in analyses of data from two previously published studies, that the VTE risk declined with PCSK9 inhibition, especially...
5 important trials in Preventive Cardiology that came in 2015 Dr. Manav Aggarwal30 Dec 2015 10:47 AM ISTThe field of preventive cardiology say some major developments and researches coming out in the year 2015.Here are a few important trials that came in...
